Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Ibrutinib in Treating Patients with Refractory or Relapsed Lymphoma after Donor Stem Cell Transplant

Multiple Cancer Types

This phase II trial studies how well ibrutinib works in treating patients after a donor stem cell transplant for lymphoma that is not responding to treatment or has come back. Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Leukemia, Lymphoma
II
Jagasia, Madan
NCT02869633
VICCBMT1651

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: